PRLD — PRELUDE THERAPEUTICS INC

Ownership history in Kynam Capital Management, LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in PRELUDE THERAPEUTICS INC (PRLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.15% (2025 Q4)
Avg. % of fund
0.15%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 788,867 — — 0.15% $2.3M $2.90
% of Fund (quarterly)    PRLD price (monthly, adj. close)

Other funds also holding PRLD

As of 2025 Q4 — sorted by position size

ORBIMED ADVISORS LLC 3Y 7Y 0.65% BAKER BROS. ADVISORS LP 3Y 7Y 0.17% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.07% XTX Topco Ltd 3Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.0% CALDWELL SUTTER CAPITAL, INC. 3Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0% TWO SIGMA ADVISERS, LP 3Y 7Y 0.0%
← Back to Kynam Capital Management, LP Holdings